PAVmed Inc. (PAVM) Financial Ratios
12 years of historical data (2014–2025) · Healthcare · Medical - Devices
EV/EBITDA
N/A
—
5yr avg: N/A
P/FCF
N/A
—
5yr avg: N/A
P/B Ratio
↑
0.15
+8% vs avg
5yr avg: 0.14
30Y Low0.1·High0.2
ROE
↑
5.3%
↓+105% vs avg
5yr avg: -106.4%
30Y Low-249%·High5%
Debt/EBITDA
N/A
—
5yr avg: N/A
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
PAVM Valuation Multiples
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
PAVmed Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $3M | $4M | $1M | $993134 | $1M | $6M | $3M | $1M | $714328 | $1M | $3M |
| Enterprise Value | $14M | $16M | $32M | $30M | $-1681782 | $-70901717 | $1M | $3M | $395209 | $1M | $2M |
| P/E Ratio → | -0.87 | — | 0.04 | — | — | — | — | — | — | — | — |
| P/S Ratio | 37.14 | 62.55 | 0.46 | 0.41 | 3.78 | 12.71 | — | — | — | — | — |
| P/B Ratio | 0.15 | 0.20 | — | — | 0.13 | 0.08 | — | — | — | — | — |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — |
| P/OCF | — | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
PAVM EV Ratios
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 228.89 | 10.70 | 12.27 | -4.46 | -141.80 | — | — | — | — | — |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | — | — | 1.13 | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
PAVM Profitability
Margins and return-on-capital ratios measuring operating efficiency
PAVmed Inc. earns an operating margin of -30712.7%. Operating margins have compressed from -2805.7% to -30712.7% over the past 3 years, signaling potential cost pressures or competitive headwinds. ROE of 5.3% is modest.
Margins
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -354.9% | -354.9% | -101.6% | -161.8% | -858.6% | -17.0% | — | — | — | — | — |
| Operating Margin | -30712.7% | -30712.7% | -1485.4% | -2805.7% | -24161.0% | -10878.6% | — | — | — | — | — |
| Net Profit Margin | 564.8% | 564.8% | 1328.6% | -2617.3% | -23602.9% | -10069.4% | — | — | — | — | — |
Return on Capital
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 5.3% | 5.3% | — | — | -197.0% | -127.5% | — | — | — | — | -3589.5% |
| ROA | 1.2% | 1.2% | 124.8% | -147.4% | -126.3% | -94.3% | -253.7% | -202.5% | -354.5% | -758.5% | -542.2% |
| ROIC | -56.6% | -56.6% | -232.4% | -800.3% | -1368.1% | — | — | — | — | — | — |
| ROCE | -227.3% | -227.3% | — | — | -197.6% | -137.8% | — | — | — | — | -3589.5% |
PAVM Leverage & Debt
Solvency and debt-coverage ratios — lower is generally safer
Net debt stands at $12M ($13M total debt minus $2M cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.60 | 0.60 | — | — | 3.35 | — | — | — | — | — | — |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Net Debt / Equity | — | 0.53 | — | — | -0.28 | -0.97 | — | — | — | — | — |
| Net Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — |
| Debt / FCF | — | — | — | — | — | — | — | — | — | — | — |
| Interest Coverage | -1038.38 | -1038.38 | 632.71 | -133.57 | -79.59 | — | -440.58 | -510.77 | -6.34 | -12.14 | — |
PAVM Liquidity & Efficiency
Short-term solvency ratios and asset-utilisation metrics
The current ratio of 0.17x is below 1.0, meaning current liabilities exceed current assets. The current ratio has declined from 0.45x to 0.17x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.17 | 0.17 | 0.06 | 0.45 | 1.07 | 10.93 | 0.94 | 0.55 | 0.77 | 0.64 | 0.62 |
| Quick Ratio | 0.16 | 0.16 | 0.05 | 0.44 | 1.06 | 10.86 | 0.89 | 0.55 | 0.77 | 0.64 | 0.62 |
| Cash Ratio | 0.10 | 0.10 | 0.03 | 0.36 | 1.04 | 10.49 | 0.87 | 0.52 | 0.75 | 0.60 | 0.49 |
| Asset Turnover | — | 0.00 | 0.10 | 0.07 | 0.01 | 0.01 | — | — | — | — | — |
| Inventory Turnover | 1.35 | 1.35 | 22.70 | 11.91 | 13.85 | 1.11 | — | — | — | — | — |
| Days Sales Outstanding | — | 77.11 | 2.19 | 9.08 | 16.46 | 146.00 | — | — | — | — | — |
PAVM Shareholder Yields
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
PAVmed Inc. does not currently pay a dividend and has no material buyback yield, reinvesting earnings back into the business.
Dividends
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | — | — | — | — | — | — | — | — | 1.0% | — | — |
| Payout Ratio | — | — | — | — | — | — | — | — | — | — | — |
Total Shareholder Return Metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | 2371.8% | — | — | — | — | — | — | — | — |
| FCF Yield | — | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | 0.0% | 0.0% | 0.0% | 25.7% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Total Shareholder Yield | 0.0% | 0.0% | 0.0% | 0.0% | 25.7% | 0.0% | 0.0% | 0.0% | 1.0% | 0.0% | 0.0% |
| Shares Outstanding | — | $670466 | $2M | $241052 | $197947 | $172257 | $105405 | $67105 | $49503 | $29991 | $28827 |
Peer Comparison
Compare PAVM with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
 PAVMYou | $3M | -0.9 | — | — | -354.9% | -30712.7% | 5.3% | -56.6% | — |
 NVCR | $2B | -11.2 | — | — | 74.5% | -23.5% | -38.9% | -16.4% | — |
 INVA | $2B | 6.9 | 6.8 | 8.5 | 72.3% | 38.5% | 29.1% | 14.2% | 1.3 |
 MGRX | $3M | -0.1 | — | — | 54.9% | -4200.5% | -141.7% | -102.2% | — |
 ATEC | $1B | -8.9 | 4030.4 | 466.2 | 69.6% | -10.7% | -630.7% | -12.6% | 1425.2 |
 GKOS | $8B | -40.0 | — | — | 77.5% | -17.1% | -26.4% | -9.2% | — |
 TMDX | $3B | 15.5 | 19.1 | 19.5 | 59.9% | 17.9% | 54.2% | 18.8% | 3.5 |
 PRCT | $1B | -12.2 | — | — | 63.7% | -33.7% | -24.9% | -55.7% | — |
 MDT | $102B | 22.0 | 14.5 | 19.6 | 65.3% | 17.8% | 9.4% | 6.0% | 3.2 |
 BSX | $66B | 22.9 | 20.4 | 18.0 | 69.0% | 19.8% | 12.4% | 8.8% | 3.3 |
 SYK | $117B | 36.3 | 21.0 | 27.2 | 64.0% | 19.5% | 15.1% | 11.4% | 2.4 |
| Healthcare Median | — | 22.1 | 14.2 | 18.4 | 63.9% | -4.4% | -33.2% | -11.7% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Download Financial Ratios Data
Includes 30+ ratios · 12 years · Updated daily
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare
PAVM — Frequently Asked Questions
Quick answers to the most common questions about buying PAVM stock.
What is PAVmed Inc.'s P/E ratio?
PAVmed Inc.'s current P/E ratio is -0.9x. The historical average is 0.0x.
What is PAVmed Inc.'s ROE?
PAVmed Inc.'s return on equity (ROE) is 5.3%. The historical average is -127.4%.
Is PAVM stock overvalued?
Based on historical data, PAVmed Inc. is trading at a P/E of -0.9x. Compare with industry peers and growth rates for a complete picture.
What are PAVmed Inc.'s profit margins?
PAVmed Inc. has -354.9% gross margin and -30712.7% operating margin.